SIMILAR PATTERNS OF AMINO ACIDS FOR 1OPJ_A_STIA3

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h4l CELL DIVISION
PROTEIN KINASE 5


(Homo sapiens)
PF00069
(Pkinase)
6 VAL A  18
ALA A  31
VAL A  64
PHE A  82
LEU A 133
ALA A 143
None
0.47A 1opjA-1h4lA:
16.4
1opjA-1h4lA:
24.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1k9a CARBOXYL-TERMINAL
SRC KINASE


(Rattus
norvegicus)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
6 ALA A 220
GLU A 236
MET A 240
VAL A 249
THR A 266
LEU A 321
None
0.56A 1opjA-1k9aA:
30.9
1opjA-1k9aA:
30.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1k9a CARBOXYL-TERMINAL
SRC KINASE


(Rattus
norvegicus)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
6 VAL A 209
ALA A 220
GLU A 236
MET A 240
VAL A 249
THR A 266
None
0.56A 1opjA-1k9aA:
30.9
1opjA-1k9aA:
30.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1opk PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Mus musculus)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
7 GLU A 305
MET A 309
ILE A 312
VAL A 318
THR A 334
LEU A 389
ALA A 399
P16  A   2 (-4.2A)
P16  A   2 (-3.3A)
None
P16  A   2 ( 4.7A)
P16  A   2 (-3.7A)
P16  A   2 (-4.4A)
P16  A   2 (-3.5A)
0.67A 1opjA-1opkA:
37.3
1opjA-1opkA:
58.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1opk PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Mus musculus)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
10 LEU A 267
VAL A 275
ALA A 288
GLU A 305
MET A 309
VAL A 318
THR A 334
PHE A 336
LEU A 389
ALA A 399
P16  A   2 ( 4.2A)
P16  A   2 (-4.5A)
P16  A   2 (-3.4A)
P16  A   2 (-4.2A)
P16  A   2 (-3.3A)
P16  A   2 ( 4.7A)
P16  A   2 (-3.7A)
P16  A   2 ( 4.4A)
P16  A   2 (-4.4A)
P16  A   2 (-3.5A)
0.60A 1opjA-1opkA:
37.3
1opjA-1opkA:
58.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1rjb FL CYTOKINE RECEPTOR

(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 616
VAL A 624
ALA A 642
GLU A 661
VAL A 675
LEU A 818
None
0.67A 1opjA-1rjbA:
32.5
1opjA-1rjbA:
35.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1t46 HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 595
VAL A 603
ALA A 621
GLU A 640
VAL A 654
THR A 670
LEU A 799
ASP A 810
STI  A   3 ( 3.8A)
STI  A   3 ( 4.6A)
STI  A   3 (-3.5A)
STI  A   3 (-3.6A)
STI  A   3 (-4.3A)
STI  A   3 (-3.2A)
STI  A   3 (-4.4A)
STI  A   3 (-3.9A)
0.55A 1opjA-1t46A:
34.0
1opjA-1t46A:
36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1u59 TYROSINE-PROTEIN
KINASE ZAP-70


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 344
VAL A 352
ALA A 367
GLU A 386
MET A 390
VAL A 399
LEU A 468
STU  A 100 (-3.8A)
STU  A 100 (-4.8A)
STU  A 100 (-3.2A)
None
None
None
STU  A 100 (-4.5A)
0.60A 1opjA-1u59A:
29.8
1opjA-1u59A:
38.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zlt SERINE/THREONINE-PRO
TEIN KINASE CHK1


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  15
VAL A  23
ALA A  36
GLU A  55
VAL A  68
LEU A 137
HYM  A 400 (-4.2A)
HYM  A 400 (-4.3A)
HYM  A 400 (-3.5A)
None
HYM  A 400 (-4.8A)
HYM  A 400 (-4.5A)
0.74A 1opjA-1zltA:
20.9
1opjA-1zltA:
24.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2buj SERINE/THREONINE-PRO
TEIN KINASE 16


(Homo sapiens)
PF00069
(Pkinase)
7 LEU A  26
VAL A  34
ALA A  47
GLU A  65
PHE A 100
LEU A 155
ASP A 166
STU  A1301 (-4.2A)
STU  A1301 (-4.8A)
STU  A1301 (-3.6A)
None
STU  A1301 (-4.5A)
STU  A1301 ( 4.8A)
None
0.72A 1opjA-2bujA:
22.7
1opjA-2bujA:
23.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN


(Homo sapiens)
PF07714
(Pkinase_Tyr)
9 LEU X  17
VAL X  25
ALA X  37
GLU X  54
MET X  58
VAL X  67
THR X  82
LEU X 137
ALA X 147
STU  X 902 (-3.8A)
STU  X 902 ( 4.8A)
STU  X 902 (-3.1A)
STU  X 902 ( 4.4A)
None
None
STU  X 902 (-4.1A)
STU  X 902 (-4.4A)
STU  X 902 ( 4.1A)
0.66A 1opjA-2dq7X:
31.7
1opjA-2dq7X:
44.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eu9 DUAL SPECIFICITY
PROTEIN KINASE CLK3


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A 162
VAL A 170
ALA A 184
GLU A 201
ILE A 208
ALA A 319
None
0.59A 1opjA-2eu9A:
13.7
1opjA-2eu9A:
23.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eu9 DUAL SPECIFICITY
PROTEIN KINASE CLK3


(Homo sapiens)
PF00069
(Pkinase)
7 LEU A 162
VAL A 170
ALA A 184
GLU A 201
VAL A 220
LEU A 290
ALA A 319
None
0.56A 1opjA-2eu9A:
13.7
1opjA-2eu9A:
23.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h8h PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC


(Homo sapiens)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
7 LEU A 273
VAL A 281
ALA A 293
VAL A 323
THR A 338
LEU A 393
ALA A 403
H8H  A 534 (-3.8A)
H8H  A 534 (-4.4A)
H8H  A 534 (-3.2A)
None
H8H  A 534 (-3.1A)
H8H  A 534 (-4.5A)
H8H  A 534 ( 4.0A)
0.85A 1opjA-2h8hA:
29.7
1opjA-2h8hA:
28.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hck HEMATOPOETIC CELL
KINASE HCK


(Homo sapiens)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
6 LEU A 273
VAL A 281
ALA A 293
VAL A 323
THR A 338
PHE A 340
QUE  A   1 (-3.9A)
QUE  A   1 ( 4.8A)
QUE  A   1 (-3.5A)
None
QUE  A   1 (-3.3A)
QUE  A   1 (-4.2A)
0.67A 1opjA-2hckA:
29.4
1opjA-2hckA:
30.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hk5 TYROSINE-PROTEIN
KINASE HCK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 251
ALA A 271
MET A 292
VAL A 301
THR A 316
PHE A 318
ALA A 381
ASP A 382
1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
0.89A 1opjA-2hk5A:
26.5
1opjA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hk5 TYROSINE-PROTEIN
KINASE HCK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
PHE A 318
1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
0.63A 1opjA-2hk5A:
26.5
1opjA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hk5 TYROSINE-PROTEIN
KINASE HCK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
9 LEU A 251
VAL A 259
ALA A 271
MET A 292
VAL A 301
THR A 316
PHE A 318
LEU A 371
ALA A 381
1BM  A 499 ( 3.7A)
1BM  A 499 ( 4.8A)
1BM  A 499 (-3.6A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 (-3.2A)
1BM  A 499 (-4.1A)
1BM  A 499 (-4.4A)
1BM  A 499 ( 3.7A)
0.88A 1opjA-2hk5A:
26.5
1opjA-2hk5A:
46.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 GLU A 286
MET A 290
ILE A 293
VAL A 299
THR A 315
PHE A 317
ALA A 380
ASP A 381
GIN  A 600 (-3.6A)
GIN  A 600 (-3.2A)
GIN  A 600 (-4.5A)
GIN  A 600 (-4.6A)
GIN  A 600 (-3.4A)
GIN  A 600 (-4.3A)
GIN  A 600 (-3.1A)
GIN  A 600 (-4.9A)
0.75A 1opjA-2hz0A:
34.5
1opjA-2hz0A:
97.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
10 LEU A 248
VAL A 256
ALA A 269
GLU A 286
MET A 290
ILE A 293
VAL A 299
THR A 315
PHE A 317
ALA A 380
GIN  A 600 ( 4.6A)
GIN  A 600 ( 4.7A)
GIN  A 600 (-3.1A)
GIN  A 600 (-3.6A)
GIN  A 600 (-3.2A)
GIN  A 600 (-4.5A)
GIN  A 600 (-4.6A)
GIN  A 600 (-3.4A)
GIN  A 600 (-4.3A)
GIN  A 600 (-3.1A)
0.62A 1opjA-2hz0A:
34.5
1opjA-2hz0A:
97.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
10 LEU A 248
VAL A 256
ALA A 269
GLU A 286
MET A 290
VAL A 299
THR A 315
PHE A 317
LEU A 370
ALA A 380
GIN  A 600 ( 4.6A)
GIN  A 600 ( 4.7A)
GIN  A 600 (-3.1A)
GIN  A 600 (-3.6A)
GIN  A 600 (-3.2A)
GIN  A 600 (-4.6A)
GIN  A 600 (-3.4A)
GIN  A 600 (-4.3A)
GIN  A 600 (-4.7A)
GIN  A 600 (-3.1A)
0.54A 1opjA-2hz0A:
34.5
1opjA-2hz0A:
97.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j0j FOCAL ADHESION
KINASE 1


(Gallus gallus)
PF00373
(FERM_M)
PF07714
(Pkinase_Tyr)
6 VAL A 436
ALA A 452
GLU A 471
MET A 475
VAL A 484
LEU A 553
4ST  A1687 ( 4.8A)
4ST  A1687 (-3.3A)
4ST  A1687 ( 4.6A)
None
None
4ST  A1687 (-4.4A)
0.65A 1opjA-2j0jA:
31.6
1opjA-2j0jA:
20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jgz CELL DIVISION
PROTEIN KINASE 2


(Homo sapiens)
PF00069
(Pkinase)
7 VAL A  18
ALA A  31
GLU A  51
VAL A  64
PHE A  82
LEU A 134
ALA A 144
None
0.64A 1opjA-2jgzA:
16.3
1opjA-2jgzA:
28.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2og8 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
10 LEU A 251
VAL A 259
ALA A 271
GLU A 288
MET A 292
VAL A 301
THR A 316
LEU A 371
ALA A 381
ASP A 382
None
None
1N8  A 501 ( 3.4A)
1N8  A 501 ( 3.6A)
1N8  A 501 ( 3.6A)
None
1N8  A 501 ( 3.3A)
1N8  A 501 ( 4.3A)
1N8  A 501 ( 3.3A)
1N8  A 501 ( 3.3A)
0.66A 1opjA-2og8A:
26.1
1opjA-2og8A:
45.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ogv MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR
PRECURSOR


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 588
ALA A 614
GLU A 633
MET A 637
VAL A 647
THR A 663
ASP A 796
None
0.92A 1opjA-2ogvA:
22.0
1opjA-2ogvA:
38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ogv MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR
PRECURSOR


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 588
VAL A 596
ALA A 614
GLU A 633
MET A 637
VAL A 647
THR A 663
LEU A 785
None
0.85A 1opjA-2ogvA:
22.0
1opjA-2ogvA:
38.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2psq FIBROBLAST GROWTH
FACTOR RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 487
VAL A 495
ALA A 515
GLU A 534
MET A 538
ILE A 541
LEU A 633
ALA A 643
None
0.60A 1opjA-2psqA:
31.3
1opjA-2psqA:
35.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qlu ACTIVIN RECEPTOR
TYPE IIB


(Homo sapiens)
PF00069
(Pkinase)
6 VAL A 204
ALA A 215
THR A 265
PHE A 267
LEU A 328
ALA A 338
ADE  A 488 ( 4.9A)
ADE  A 488 (-3.2A)
ADE  A 488 (-4.3A)
ADE  A 488 (-4.3A)
ADE  A 488 (-4.4A)
None
0.69A 1opjA-2qluA:
24.2
1opjA-2qluA:
24.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2r4b RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-4


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 724
VAL A 732
ALA A 749
VAL A 781
THR A 796
LEU A 850
GW7  A   1 ( 4.2A)
GW7  A   1 ( 4.8A)
GW7  A   1 (-3.3A)
GW7  A   1 ( 4.7A)
GW7  A   1 (-4.0A)
GW7  A   1 (-4.2A)
0.72A 1opjA-2r4bA:
28.8
1opjA-2r4bA:
36.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z7r RIBOSOMAL PROTEIN S6
KINASE ALPHA-1


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  68
VAL A  76
ALA A  92
VAL A 125
PHE A 143
LEU A 194
STU  A   1 (-3.8A)
None
STU  A   1 (-3.3A)
None
STU  A   1 (-4.6A)
STU  A   1 (-4.6A)
0.51A 1opjA-2z7rA:
21.2
1opjA-2z7rA:
26.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2z8c INSULIN RECEPTOR

(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A1002
VAL A1010
ALA A1028
GLU A1047
MET A1051
VAL A1060
S91  A   1 ( 4.1A)
S91  A   1 ( 4.9A)
S91  A   1 (-3.2A)
None
None
None
0.51A 1opjA-2z8cA:
28.8
1opjA-2z8cA:
38.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2zv7 TYROSINE-PROTEIN
KINASE LYN


(Mus musculus)
PF07714
(Pkinase_Tyr)
7 VAL A 261
ALA A 273
VAL A 303
THR A 319
PHE A 321
ALA A 384
ASP A 385
None
0.73A 1opjA-2zv7A:
25.4
1opjA-2zv7A:
46.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2zv7 TYROSINE-PROTEIN
KINASE LYN


(Mus musculus)
PF07714
(Pkinase_Tyr)
7 VAL A 261
ALA A 273
VAL A 303
THR A 319
PHE A 321
LEU A 374
ALA A 384
None
0.87A 1opjA-2zv7A:
25.4
1opjA-2zv7A:
46.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3b2t FIBROBLAST GROWTH
FACTOR RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 487
VAL A 495
ALA A 515
GLU A 534
MET A 538
ILE A 541
M33  A1996 (-4.0A)
M33  A1996 ( 4.7A)
M33  A1996 (-3.3A)
None
None
None
0.64A 1opjA-3b2tA:
24.3
1opjA-3b2tA:
39.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3b2t FIBROBLAST GROWTH
FACTOR RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 487
VAL A 495
ALA A 515
MET A 538
ILE A 541
LEU A 633
ALA A 643
M33  A1996 (-4.0A)
M33  A1996 ( 4.7A)
M33  A1996 (-3.3A)
None
None
M33  A1996 (-4.5A)
None
0.68A 1opjA-3b2tA:
24.3
1opjA-3b2tA:
39.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3c4f BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 484
VAL A 492
ALA A 512
GLU A 531
ILE A 538
LEU A 630
ALA A 640
C4F  A   1 ( 3.9A)
None
C4F  A   1 (-3.3A)
None
None
C4F  A   1 (-4.6A)
C4F  A   1 (-3.6A)
0.63A 1opjA-3c4fA:
31.6
1opjA-3c4fA:
39.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3c4f BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 484
VAL A 492
ALA A 512
MET A 535
ILE A 538
LEU A 630
ALA A 640
C4F  A   1 ( 3.9A)
None
C4F  A   1 (-3.3A)
C4F  A   1 ( 3.7A)
None
C4F  A   1 (-4.6A)
C4F  A   1 (-3.6A)
0.63A 1opjA-3c4fA:
31.6
1opjA-3c4fA:
39.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3d7u TYROSINE-PROTEIN
KINASE CSK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 220
GLU A 236
MET A 240
VAL A 249
THR A 266
LEU A 321
None
0.56A 1opjA-3d7uA:
26.5
1opjA-3d7uA:
44.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3d7u TYROSINE-PROTEIN
KINASE CSK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 VAL A 209
ALA A 220
GLU A 236
MET A 240
VAL A 249
THR A 266
None
0.56A 1opjA-3d7uA:
26.5
1opjA-3d7uA:
44.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dko EPHRIN TYPE-A
RECEPTOR 7


(Homo sapiens)
PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM)
6 ALA A 663
GLU A 682
MET A 686
VAL A 695
PHE A 713
ASP A 776
IHZ  A1001 (-3.3A)
IHZ  A1001 (-3.8A)
IHZ  A1001 (-3.5A)
IHZ  A1001 ( 4.9A)
None
IHZ  A1001 (-4.8A)
0.73A 1opjA-3dkoA:
30.2
1opjA-3dkoA:
35.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dko EPHRIN TYPE-A
RECEPTOR 7


(Homo sapiens)
PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM)
6 VAL A 647
ALA A 663
GLU A 682
MET A 686
VAL A 695
PHE A 713
IHZ  A1001 ( 4.4A)
IHZ  A1001 (-3.3A)
IHZ  A1001 (-3.8A)
IHZ  A1001 (-3.5A)
IHZ  A1001 ( 4.9A)
None
0.68A 1opjA-3dkoA:
30.2
1opjA-3dkoA:
35.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 833
VAL A 841
ALA A 859
GLU A 878
ILE A 885
VAL A 892
LEU A1029
8ST  A2001 ( 4.7A)
8ST  A2001 ( 4.6A)
8ST  A2001 ( 3.8A)
8ST  A2001 (-3.7A)
None
8ST  A2001 ( 4.7A)
None
0.70A 1opjA-3hngA:
32.8
1opjA-3hngA:
34.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 VAL A 841
ALA A 859
GLU A 878
ILE A 885
VAL A 892
LEU A1029
ASP A1040
8ST  A2001 ( 4.6A)
8ST  A2001 ( 3.8A)
8ST  A2001 (-3.7A)
None
8ST  A2001 ( 4.7A)
None
None
0.81A 1opjA-3hngA:
32.8
1opjA-3hngA:
34.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iec SERINE/THREONINE-PRO
TEIN KINASE MARK2


(Homo sapiens)
PF00069
(Pkinase)
PF00627
(UBA)
6 VAL A  67
ALA A  80
MET A 104
VAL A 113
ALA A 192
ASP A 193
None
0.63A 1opjA-3iecA:
22.4
1opjA-3iecA:
25.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iec SERINE/THREONINE-PRO
TEIN KINASE MARK2


(Homo sapiens)
PF00069
(Pkinase)
PF00627
(UBA)
6 VAL A  67
ALA A  80
MET A 104
VAL A 113
LEU A 182
ALA A 192
None
0.73A 1opjA-3iecA:
22.4
1opjA-3iecA:
25.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mi9 CELL DIVISION
PROTEIN KINASE 9


(Homo sapiens)
PF00069
(Pkinase)
7 VAL A  33
ALA A  46
GLU A  66
VAL A  79
PHE A 105
LEU A 156
ALA A 166
None
0.64A 1opjA-3mi9A:
22.6
1opjA-3mi9A:
26.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mvj CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  49
VAL A  57
ALA A  70
GLU A  91
VAL A 104
LEU A 173
XFE  A 351 (-4.2A)
XFE  A 351 ( 4.5A)
XFE  A 351 (-3.2A)
None
None
XFE  A 351 (-4.6A)
0.74A 1opjA-3mvjA:
20.6
1opjA-3mvjA:
24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3niz RHODANESE FAMILY
PROTEIN


(Cryptosporidium
parvum)
PF00069
(Pkinase)
7 VAL A  37
ALA A  49
GLU A  69
VAL A  82
PHE A 100
LEU A 151
ALA A 161
ADP  A 314 (-4.0A)
ADP  A 314 (-3.5A)
None
None
ADP  A 314 ( 4.3A)
ADP  A 314 (-4.6A)
None
0.78A 1opjA-3nizA:
22.5
1opjA-3nizA:
26.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nuu PKB-LIKE

(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  88
VAL A  96
ALA A 109
GLU A 130
MET A 134
LEU A 212
JOZ  A 361 (-4.1A)
JOZ  A 361 ( 4.7A)
JOZ  A 361 (-3.4A)
SO4  A   5 (-3.1A)
None
None
0.57A 1opjA-3nuuA:
22.5
1opjA-3nuuA:
25.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3sxs CYTOPLASMIC
TYROSINE-PROTEIN
KINASE BMX


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 423
VAL A 431
ALA A 443
MET A 464
VAL A 473
THR A 489
LEU A 543
PP2  A   1 (-4.1A)
PP2  A   1 (-4.5A)
PP2  A   1 (-3.2A)
PP2  A   1 ( 4.3A)
None
PP2  A   1 (-3.3A)
PP2  A   1 (-4.6A)
0.66A 1opjA-3sxsA:
31.0
1opjA-3sxsA:
41.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tt0 BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 484
VAL A 492
ALA A 512
GLU A 531
MET A 535
ILE A 538
LEU A 630
ALA A 640
07J  A   1 ( 4.3A)
07J  A   1 (-4.0A)
07J  A   1 (-3.5A)
07J  A   1 (-3.8A)
07J  A   1 (-3.8A)
None
07J  A   1 ( 4.4A)
07J  A   1 (-3.2A)
0.62A 1opjA-3tt0A:
30.5
1opjA-3tt0A:
34.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 840
VAL A 848
ALA A 866
GLU A 885
ILE A 892
VAL A 899
PHE A 918
LEU A1035
4TT  A2001 ( 4.0A)
4TT  A2001 ( 4.5A)
4TT  A2001 (-3.5A)
None
None
None
4TT  A2001 (-4.5A)
4TT  A2001 (-4.8A)
0.68A 1opjA-3vidA:
29.9
1opjA-3vidA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 840
VAL A 848
ALA A 866
ILE A 892
VAL A 899
PHE A 918
LEU A1035
ASP A1046
4TT  A2001 ( 4.0A)
4TT  A2001 ( 4.5A)
4TT  A2001 (-3.5A)
None
None
4TT  A2001 (-4.5A)
4TT  A2001 (-4.8A)
None
0.77A 1opjA-3vidA:
29.9
1opjA-3vidA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3wzd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 840
VAL A 848
ALA A 866
GLU A 885
VAL A 899
PHE A 918
LEU A1035
LEV  A1201 ( 3.8A)
LEV  A1201 ( 4.9A)
LEV  A1201 (-3.5A)
LEV  A1201 (-3.7A)
None
LEV  A1201 (-4.7A)
LEV  A1201 (-4.8A)
0.62A 1opjA-3wzdA:
30.8
1opjA-3wzdA:
37.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3wzd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 840
VAL A 848
ALA A 866
ILE A 892
VAL A 899
PHE A 918
LEU A1035
LEV  A1201 ( 3.8A)
LEV  A1201 ( 4.9A)
LEV  A1201 (-3.5A)
None
None
LEV  A1201 (-4.7A)
LEV  A1201 (-4.8A)
0.64A 1opjA-3wzdA:
30.8
1opjA-3wzdA:
37.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zdu CYCLIN-DEPENDENT
KINASE-LIKE 3


(Homo sapiens)
PF00069
(Pkinase)
6 VAL A  18
ALA A  31
GLU A  50
VAL A  63
PHE A  81
LEU A 132
38R  A 350 ( 4.8A)
38R  A 350 (-3.4A)
38R  A 350 ( 4.8A)
38R  A 350 ( 4.9A)
38R  A 350 (-4.2A)
38R  A 350 (-4.3A)
0.49A 1opjA-3zduA:
22.3
1opjA-3zduA:
28.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3zfx EPHRIN TYPE-B
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 VAL A 633
ALA A 649
GLU A 668
MET A 672
THR A 697
PHE A 699
None
0.75A 1opjA-3zfxA:
31.5
1opjA-3zfxA:
40.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4agd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 840
ALA A 866
GLU A 885
ILE A 892
VAL A 899
PHE A 918
LEU A1035
ASP A1046
B49  A2000 (-3.7A)
B49  A2000 (-3.5A)
None
None
B49  A2000 ( 4.6A)
B49  A2000 (-4.4A)
B49  A2000 (-4.5A)
None
0.69A 1opjA-4agdA:
32.4
1opjA-4agdA:
35.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4agd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 840
VAL A 848
ALA A 866
GLU A 885
ILE A 892
VAL A 899
PHE A 918
LEU A1035
B49  A2000 (-3.7A)
None
B49  A2000 (-3.5A)
None
None
B49  A2000 ( 4.6A)
B49  A2000 (-4.4A)
B49  A2000 (-4.5A)
0.68A 1opjA-4agdA:
32.4
1opjA-4agdA:
35.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bc6 SERINE/THREONINE-PRO
TEIN KINASE 10


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  42
VAL A  50
ALA A  63
VAL A  94
LEU A 164
ALA A 174
XZN  A1317 (-3.6A)
XZN  A1317 ( 4.7A)
XZN  A1317 (-3.5A)
XZN  A1317 (-4.4A)
XZN  A1317 (-4.7A)
XZN  A1317 ( 4.3A)
0.61A 1opjA-4bc6A:
21.2
1opjA-4bc6A:
28.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bc6 SERINE/THREONINE-PRO
TEIN KINASE 10


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  42
VAL A  50
ALA A  63
VAL A  94
PHE A 112
ALA A 174
XZN  A1317 (-3.6A)
XZN  A1317 ( 4.7A)
XZN  A1317 (-3.5A)
XZN  A1317 (-4.4A)
XZN  A1317 (-4.5A)
XZN  A1317 ( 4.3A)
0.50A 1opjA-4bc6A:
21.2
1opjA-4bc6A:
28.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ckr EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
9 LEU A 616
VAL A 624
ALA A 653
GLU A 672
MET A 676
THR A 701
LEU A 773
ALA A 783
ASP A 784
None
DI1  A1000 (-4.8A)
DI1  A1000 (-3.6A)
DI1  A1000 (-3.8A)
DI1  A1000 (-3.6A)
DI1  A1000 (-3.6A)
DI1  A1000 (-4.5A)
DI1  A1000 (-3.7A)
DI1  A1000 (-4.1A)
0.70A 1opjA-4ckrA:
32.1
1opjA-4ckrA:
37.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4crs SERINE/THREONINE-PRO
TEIN KINASE N2


(Homo sapiens)
PF00069
(Pkinase)
PF00433
(Pkinase_C)
7 LEU A 663
VAL A 671
ALA A 684
GLU A 705
VAL A 721
LEU A 789
ALA A 799
AGS  A1985 (-4.2A)
AGS  A1985 (-4.6A)
AGS  A1985 (-3.5A)
None
None
AGS  A1985 (-4.8A)
AGS  A1985 ( 4.5A)
0.69A 1opjA-4crsA:
15.9
1opjA-4crsA:
26.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gl9 TYROSINE-PROTEIN
KINASE


(Mus musculus)
PF07714
(Pkinase_Tyr)
6 LEU A 855
VAL A 863
ALA A 880
GLU A 898
VAL A 911
LEU A 983
IZA  A2001 (-3.7A)
None
IZA  A2001 (-3.4A)
None
None
IZA  A2001 ( 4.7A)
0.70A 1opjA-4gl9A:
19.7
1opjA-4gl9A:
34.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hvi TYROSINE-PROTEIN
KINASE JAK3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 828
VAL A 836
ALA A 853
GLU A 871
VAL A 884
LEU A 956
ALA A 966
19S  A1201 (-3.9A)
19S  A1201 (-4.4A)
19S  A1201 (-3.3A)
None
None
19S  A1201 (-4.5A)
19S  A1201 ( 4.1A)
0.58A 1opjA-4hviA:
29.5
1opjA-4hviA:
35.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4k33 FIBROBLAST GROWTH
FACTOR RECEPTOR 3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 478
ALA A 506
GLU A 525
MET A 529
ILE A 532
LEU A 624
ALA A 634
ACP  A 801 (-3.8A)
ACP  A 801 (-3.3A)
ACP  A 801 ( 4.8A)
None
None
ACP  A 801 (-4.4A)
None
0.75A 1opjA-4k33A:
25.3
1opjA-4k33A:
37.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4k33 FIBROBLAST GROWTH
FACTOR RECEPTOR 3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 478
VAL A 486
ALA A 506
GLU A 525
MET A 529
ILE A 532
ALA A 634
ACP  A 801 (-3.8A)
ACP  A 801 (-4.2A)
ACP  A 801 (-3.3A)
ACP  A 801 ( 4.8A)
None
None
None
0.58A 1opjA-4k33A:
25.3
1opjA-4k33A:
37.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o38 CYCLIN-G-ASSOCIATED
KINASE


(Homo sapiens)
PF00069
(Pkinase)
8 LEU A  46
VAL A  54
ALA A  67
GLU A  85
MET A  89
VAL A  99
THR A 123
LEU A 180
SIN  A 401 ( 3.9A)
None
SIN  A 401 ( 3.7A)
None
None
None
None
SIN  A 401 ( 4.5A)
0.76A 1opjA-4o38A:
19.4
1opjA-4o38A:
26.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q9z HUMAN PROTEIN KINASE
C THETA


(Homo sapiens)
PF00069
(Pkinase)
PF00433
(Pkinase_C)
6 LEU A 386
VAL A 394
ALA A 407
GLU A 428
LEU A 511
ALA A 521
PZW  A 801 (-3.9A)
PZW  A 801 (-4.6A)
PZW  A 801 (-3.5A)
None
PZW  A 801 (-4.8A)
PZW  A 801 ( 4.6A)
0.73A 1opjA-4q9zA:
15.0
1opjA-4q9zA:
26.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4rt7 RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 616
VAL A 624
ALA A 642
GLU A 661
VAL A 675
LEU A 818
ASP A 829
P30  A1001 (-3.8A)
None
P30  A1001 (-3.4A)
P30  A1001 (-3.6A)
None
P30  A1001 (-4.6A)
None
0.61A 1opjA-4rt7A:
28.0
1opjA-4rt7A:
31.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ueu TYROSINE KINASE AS -
A COMMON ANCESTOR OF
SRC AND ABL


(synthetic
construct)
PF07714
(Pkinase_Tyr)
6 LEU A  14
VAL A  22
VAL A  65
THR A  81
LEU A 136
ALA A 146
ACP  A1264 ( 4.5A)
ACP  A1264 (-4.7A)
None
ACP  A1264 (-4.5A)
ACP  A1264 ( 4.8A)
None
0.69A 1opjA-4ueuA:
32.3
1opjA-4ueuA:
62.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ueu TYROSINE KINASE AS -
A COMMON ANCESTOR OF
SRC AND ABL


(synthetic
construct)
PF07714
(Pkinase_Tyr)
6 VAL A  22
ALA A  35
VAL A  65
THR A  81
ALA A 146
ASP A 147
ACP  A1264 (-4.7A)
ACP  A1264 (-2.9A)
None
ACP  A1264 (-4.5A)
None
None
0.67A 1opjA-4ueuA:
32.3
1opjA-4ueuA:
62.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ueu TYROSINE KINASE AS -
A COMMON ANCESTOR OF
SRC AND ABL


(synthetic
construct)
PF07714
(Pkinase_Tyr)
6 VAL A  22
ALA A  35
VAL A  65
THR A  81
LEU A 136
ALA A 146
ACP  A1264 (-4.7A)
ACP  A1264 (-2.9A)
None
ACP  A1264 (-4.5A)
ACP  A1264 ( 4.8A)
None
0.62A 1opjA-4ueuA:
32.3
1opjA-4ueuA:
62.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wbo RHODOPSIN KINASE

(Bos taurus)
PF00069
(Pkinase)
PF00615
(RGS)
6 LEU A 193
VAL A 201
ALA A 214
GLU A 235
VAL A 248
LEU A 321
ANW  A 601 ( 4.0A)
None
ANW  A 601 (-3.4A)
None
None
ANW  A 601 (-4.9A)
0.76A 1opjA-4wboA:
21.6
1opjA-4wboA:
23.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wsq AP2-ASSOCIATED
PROTEIN KINASE 1


(Homo sapiens)
PF00069
(Pkinase)
7 LEU A  52
VAL A  60
ALA A  72
MET A  94
VAL A 104
PHE A 128
LEU A 183
KSA  A 405 ( 4.0A)
KSA  A 405 ( 4.9A)
KSA  A 405 (-3.2A)
None
None
KSA  A 405 (-4.8A)
KSA  A 405 (-4.6A)
0.57A 1opjA-4wsqA:
22.3
1opjA-4wsqA:
23.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xcu FIBROBLAST GROWTH
FACTOR RECEPTOR 4


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 473
VAL A 481
ALA A 501
GLU A 520
MET A 524
ILE A 527
ALA A 629
40M  A1002 ( 4.6A)
40M  A1002 ( 4.5A)
40M  A1002 ( 4.1A)
40M  A1002 (-3.7A)
40M  A1002 (-3.8A)
None
40M  A1002 (-3.0A)
0.63A 1opjA-4xcuA:
31.0
1opjA-4xcuA:
38.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xcu FIBROBLAST GROWTH
FACTOR RECEPTOR 4


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 473
VAL A 481
ALA A 501
GLU A 520
MET A 524
LEU A 619
ALA A 629
40M  A1002 ( 4.6A)
40M  A1002 ( 4.5A)
40M  A1002 ( 4.1A)
40M  A1002 (-3.7A)
40M  A1002 (-3.8A)
40M  A1002 (-4.5A)
40M  A1002 (-3.0A)
0.51A 1opjA-4xcuA:
31.0
1opjA-4xcuA:
38.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xey TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
no annotation 7 LEU B 267
VAL B 275
ILE B 312
VAL B 318
PHE B 336
LEU B 389
ALA B 399
1N1  B 601 (-3.7A)
1N1  B 601 ( 4.9A)
None
1N1  B 601 ( 4.3A)
1N1  B 601 ( 4.2A)
1N1  B 601 (-4.3A)
1N1  B 601 (-3.5A)
0.88A 1opjA-4xeyB:
34.0
1opjA-4xeyB:
71.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xey TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
no annotation 8 VAL B 275
ALA B 288
MET B 309
ILE B 312
VAL B 318
PHE B 336
LEU B 389
ALA B 399
1N1  B 601 ( 4.9A)
1N1  B 601 (-3.5A)
1N1  B 601 (-3.7A)
None
1N1  B 601 ( 4.3A)
1N1  B 601 ( 4.2A)
1N1  B 601 (-4.3A)
1N1  B 601 (-3.5A)
0.80A 1opjA-4xeyB:
34.0
1opjA-4xeyB:
71.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xey TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
no annotation 8 VAL B 275
ALA B 288
MET B 309
VAL B 318
THR B 334
PHE B 336
LEU B 389
ALA B 399
1N1  B 601 ( 4.9A)
1N1  B 601 (-3.5A)
1N1  B 601 (-3.7A)
1N1  B 601 ( 4.3A)
1N1  B 601 (-3.3A)
1N1  B 601 ( 4.2A)
1N1  B 601 (-4.3A)
1N1  B 601 (-3.5A)
0.64A 1opjA-4xeyB:
34.0
1opjA-4xeyB:
71.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xuf RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 616
VAL A 624
GLU A 661
VAL A 675
LEU A 818
ASP A 829
P30  A1001 (-4.0A)
P30  A1001 ( 4.8A)
P30  A1001 (-3.1A)
None
P30  A1001 (-4.3A)
None
0.53A 1opjA-4xufA:
33.5
1opjA-4xufA:
37.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xuf RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 VAL A 624
ALA A 642
GLU A 661
VAL A 675
LEU A 818
ASP A 829
P30  A1001 ( 4.8A)
P30  A1001 (-3.5A)
P30  A1001 (-3.1A)
None
P30  A1001 (-4.3A)
None
0.46A 1opjA-4xufA:
33.5
1opjA-4xufA:
37.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y93 NON-SPECIFIC
PROTEIN-TYROSINE
KINASE,NON-SPECIFIC
PROTEIN-TYROSINE
KINASE


(Bos taurus)
PF00169
(PH)
PF00779
(BTK)
PF07714
(Pkinase_Tyr)
6 LEU A 408
VAL A 416
ALA A 428
VAL A 458
THR A 474
LEU A 528
746  A 702 (-3.8A)
746  A 702 ( 4.3A)
746  A 702 (-2.4A)
None
746  A 702 (-3.7A)
746  A 702 (-4.4A)
0.74A 1opjA-4y93A:
30.3
1opjA-4y93A:
29.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yc6 CYCLIN-DEPENDENT
KINASE 1


(Homo sapiens)
PF00069
(Pkinase)
6 VAL A  18
ALA A  31
VAL A  64
PHE A  82
LEU A 135
ALA A 145
None
0.70A 1opjA-4yc6A:
21.9
1opjA-4yc6A:
27.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yff SERINE/THREONINE-PRO
TEIN KINASE TNNI3K


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 VAL A 477
ALA A 488
GLU A 509
THR A 539
LEU A 595
ALA A 605
None
4CV  A 801 (-3.5A)
None
4CV  A 801 (-2.8A)
4CV  A 801 (-4.4A)
4CV  A 801 ( 3.9A)
0.71A 1opjA-4yffA:
18.8
1opjA-4yffA:
28.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5a46 FIBROBLAST GROWTH
FACTOR RECEPTOR 1
(FMS-RELATED
TYROSINE KINASE 2,
PFEIFFER SYNDROME),
ISOFORM CRA_B


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 484
VAL A 492
ALA A 512
GLU A 531
MET A 535
ILE A 538
LEU A 630
ALA A 640
38O  A1769 (-3.2A)
38O  A1769 (-4.5A)
38O  A1769 (-3.6A)
EDO  A1766 (-4.1A)
EDO  A1766 (-3.5A)
None
38O  A1769 (-4.6A)
EDO  A1766 ( 4.4A)
0.67A 1opjA-5a46A:
30.5
1opjA-5a46A:
35.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e8y TGF-BETA RECEPTOR
TYPE-2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 VAL A 258
ALA A 275
GLU A 290
THR A 325
PHE A 327
LEU A 386
STU  A 601 (-4.0A)
STU  A 601 (-3.1A)
STU  A 601 ( 3.8A)
STU  A 601 ( 3.7A)
STU  A 601 (-3.4A)
STU  A 601 (-3.9A)
0.67A 1opjA-5e8yA:
6.3
1opjA-5e8yA:
29.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eyk AURORA KINASE B-A

(Xenopus laevis)
PF00069
(Pkinase)
6 LEU A  99
VAL A 107
ALA A 120
PHE A 172
ALA A 233
ASP A 234
5U5  A 401 (-3.8A)
5U5  A 401 ( 4.3A)
5U5  A 401 (-3.5A)
5U5  A 401 (-4.5A)
None
None
0.52A 1opjA-5eykA:
17.0
1opjA-5eykA:
24.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eyk AURORA KINASE B-A

(Xenopus laevis)
PF00069
(Pkinase)
6 LEU A  99
VAL A 107
ALA A 120
PHE A 172
LEU A 223
ALA A 233
5U5  A 401 (-3.8A)
5U5  A 401 ( 4.3A)
5U5  A 401 (-3.5A)
5U5  A 401 (-4.5A)
5U5  A 401 (-4.7A)
None
0.70A 1opjA-5eykA:
17.0
1opjA-5eykA:
24.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5grn PLATELET-DERIVED
GROWTH FACTOR
RECEPTOR ALPHA


(Homo sapiens)
PF07714
(Pkinase_Tyr)
9 LEU A 599
VAL A 607
ALA A 625
GLU A 644
MET A 648
VAL A 658
THR A 674
LEU A 825
ASP A 836
748  A1001 (-3.8A)
748  A1001 ( 4.7A)
748  A1001 (-3.7A)
748  A1001 (-3.3A)
748  A1001 (-3.4A)
748  A1001 ( 4.8A)
748  A1001 (-3.2A)
748  A1001 (-4.3A)
748  A1001 (-4.8A)
0.58A 1opjA-5grnA:
28.3
1opjA-5grnA:
35.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hu3 CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE TYPE II ALPHA
CHAIN


(Drosophila
melanogaster)
PF00069
(Pkinase)
7 LEU A  20
VAL A  28
ALA A  41
GLU A  61
VAL A  74
LEU A 143
ALA A 156
ADP  A 301 ( 4.0A)
ADP  A 301 (-3.7A)
ADP  A 301 (-3.5A)
None
None
ADP  A 301 (-4.7A)
ADP  A 301 ( 4.8A)
0.73A 1opjA-5hu3A:
23.0
1opjA-5hu3A:
27.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i3o BMP-2-INDUCIBLE
PROTEIN KINASE


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  57
VAL A  65
ALA A  77
MET A  99
VAL A 109
LEU A 187
IDV  A 401 (-3.8A)
IDV  A 401 (-4.6A)
IDV  A 401 (-3.6A)
None
None
IDV  A 401 (-4.4A)
0.53A 1opjA-5i3oA:
22.2
1opjA-5i3oA:
23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j5t MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE KINASE
3


(Homo sapiens)
PF00069
(Pkinase)
7 VAL A  30
ALA A  43
GLU A  61
MET A  65
PHE A  92
LEU A 143
ALA A 153
6G2  A 901 ( 4.9A)
6G2  A 901 (-3.2A)
None
None
6G2  A 901 (-4.1A)
6G2  A 901 (-4.7A)
6G2  A 901 ( 4.2A)
0.68A 1opjA-5j5tA:
21.1
1opjA-5j5tA:
24.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j5t MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE KINASE
3


(Homo sapiens)
PF00069
(Pkinase)
7 VAL A  30
ALA A  43
MET A  65
VAL A  74
PHE A  92
LEU A 143
ALA A 153
6G2  A 901 ( 4.9A)
6G2  A 901 (-3.2A)
None
None
6G2  A 901 (-4.1A)
6G2  A 901 (-4.7A)
6G2  A 901 ( 4.2A)
0.67A 1opjA-5j5tA:
21.1
1opjA-5j5tA:
24.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5l6o EPHRIN TYPE-B
RECEPTOR 3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 VAL A 647
ALA A 663
THR A 711
PHE A 713
LEU A 765
ASP A 776
None
6P6  A1001 (-3.3A)
6P6  A1001 (-3.5A)
6P6  A1001 ( 4.5A)
6P6  A1001 (-4.5A)
None
0.65A 1opjA-5l6oA:
32.8
1opjA-5l6oA:
37.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lpy PROTEIN
BRASSINOSTEROID
INSENSITIVE 1


(Arabidopsis
thaliana)
PF00069
(Pkinase)
6 VAL A 897
ALA A 909
GLU A 927
VAL A 940
PHE A 958
LEU A1016
ATP  A1200 ( 4.5A)
ATP  A1200 (-3.5A)
None
None
ATP  A1200 ( 4.0A)
ATP  A1200 (-4.6A)
0.63A 1opjA-5lpyA:
22.8
1opjA-5lpyA:
28.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5w5j RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2


(Homo sapiens)
no annotation 6 LEU A  24
VAL A  32
ALA A  45
THR A  95
LEU A 153
ALA A 163
9WS  A 401 ( 4.2A)
9WS  A 401 ( 4.6A)
9WS  A 401 (-3.3A)
9WS  A 401 (-3.2A)
9WS  A 401 (-4.6A)
9WS  A 401 ( 4.0A)
0.68A 1opjA-5w5jA:
23.1
1opjA-5w5jA:
28.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b3e CYCLIN-DEPENDENT
KINASE 12


(Homo sapiens)
no annotation 6 VAL A 741
ALA A 754
GLU A 774
VAL A 787
LEU A 866
ALA A 876
None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
0.49A 1opjA-6b3eA:
22.8
1opjA-6b3eA:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c7y TYROSINE-PROTEIN
KINASE JAK1


(Homo sapiens)
no annotation 7 LEU A 881
VAL A 889
ALA A 906
GLU A 925
VAL A 938
PHE A 958
LEU A1010
ADP  A1201 ( 4.5A)
ADP  A1201 (-4.3A)
ADP  A1201 (-3.4A)
None
None
None
ADP  A1201 (-4.5A)
0.71A 1opjA-6c7yA:
28.1
1opjA-6c7yA:
14.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fdy -

(-)
no annotation 6 LEU U  20
VAL U  28
ALA U  42
VAL U  75
PHE U  93
ALA U 156
DB8  U 301 (-3.7A)
DB8  U 301 ( 4.8A)
DB8  U 301 (-3.6A)
DB8  U 301 (-4.8A)
DB8  U 301 ( 4.4A)
DB8  U 301 ( 4.2A)
0.75A 1opjA-6fdyU:
21.7
1opjA-6fdyU:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cg4 PROTEIN
(ADENYLOSUCCINATE
SYNTHETASE)


(Escherichia
coli)
PF00709
(Adenylsucc_synt)
4 TYR A  33
VAL A  51
ILE A  55
MET A 219
None
1.29A 1opjA-1cg4A:
0.0
1opjA-1cg4A:
22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gkp HYDANTOINASE

(Thermus sp.)
PF01979
(Amidohydro_1)
4 TYR A 414
VAL A 345
ILE A 341
MET A 287
None
1.45A 1opjA-1gkpA:
0.0
1opjA-1gkpA:
22.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1opk PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Mus musculus)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
4 LYS A 290
VAL A 308
ILE A 332
MET A 337
P16  A   2 (-4.5A)
None
P16  A   2 (-4.1A)
None
0.55A 1opjA-1opkA:
37.3
1opjA-1opkA:
58.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1opk PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Mus musculus)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
4 TYR A 272
VAL A 308
ILE A 332
MET A 337
P16  A   2 (-3.6A)
None
P16  A   2 (-4.1A)
None
0.75A 1opjA-1opkA:
37.3
1opjA-1opkA:
58.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pgs PEPTIDE-N(4)-(N-ACET
YL-BETA-D-GLUCOSAMIN
YL)ASPARAGINE
AMIDASE F


(Elizabethkingia
meningoseptica)
PF09112
(N-glycanase_N)
PF09113
(N-glycanase_C)
4 TYR A 142
LYS A 302
VAL A 100
ILE A 300
None
1.49A 1opjA-1pgsA:
0.0
1opjA-1pgsA:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qhg ATP-DEPENDENT
HELICASE PCRA


(Geobacillus
stearothermophilus)
PF00580
(UvrD-helicase)
PF13361
(UvrD_C)
4 TYR A 387
LYS A 385
VAL A 559
ILE A 380
None
1.35A 1opjA-1qhgA:
0.0
1opjA-1qhgA:
17.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qhh PROTEIN (PCRA
(SUBUNIT))


(Geobacillus
stearothermophilus)
PF00580
(UvrD-helicase)
PF13361
(UvrD_C)
4 TYR B 387
LYS B 385
VAL D 559
ILE B 380
None
1.31A 1opjA-1qhhB:
0.0
1opjA-1qhhB:
19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qwj CYTIDINE
MONOPHOSPHO-N-ACETYL
NEURAMINIC ACID
SYNTHETASE


(Mus musculus)
PF02348
(CTP_transf_3)
4 TYR A 235
VAL A 137
ILE A 159
MET A 238
None
1.46A 1opjA-1qwjA:
0.0
1opjA-1qwjA:
21.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hk5 TYROSINE-PROTEIN
KINASE HCK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
4 LYS A 273
VAL A 291
ILE A 314
MET A 319
1BM  A 499 (-3.8A)
None
1BM  A 499 (-3.9A)
None
0.67A 1opjA-2hk5A:
26.4
1opjA-2hk5A:
46.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qne PUTATIVE
METHYLTRANSFERASE


(Desulfitobacterium
hafniense)
PF06253
(MTTB)
4 TYR A 217
VAL A 343
ILE A 268
MET A 210
None
1.31A 1opjA-2qneA:
undetectable
1opjA-2qneA:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rfz CELLULOSE
1,4-BETA-CELLOBIOSID
ASE


(Melanocarpus
albomyces)
PF00840
(Glyco_hydro_7)
4 TYR A 109
VAL A 288
ILE A 419
MET A 359
None
1.37A 1opjA-2rfzA:
undetectable
1opjA-2rfzA:
21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c6c 3-KETO-5-AMINOHEXANO
ATE CLEAVAGE ENZYME


(Cupriavidus
pinatubonensis)
PF05853
(BKACE)
4 TYR A 254
VAL A 135
ILE A 227
MET A  24
None
None
PEG  A 303 ( 4.7A)
None
1.50A 1opjA-3c6cA:
undetectable
1opjA-3c6cA:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fn5 SORTASE A

(Streptococcus
pyogenes)
PF04203
(Sortase)
4 TYR A 178
LYS A 220
VAL A 191
ILE A 218
None
1.34A 1opjA-3fn5A:
undetectable
1opjA-3fn5A:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ib5 SEX PHEROMONE
PRECURSOR


(Lactobacillus
salivarius)
PF07537
(CamS)
4 TYR A 240
VAL A 246
ILE A  91
MET A 174
None
EDO  A   3 ( 4.0A)
None
None
1.37A 1opjA-3ib5A:
undetectable
1opjA-3ib5A:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jtw DIHYDROFOLATE
REDUCTASE


(Pediococcus
pentosaceus)
PF01872
(RibD_C)
4 TYR A 171
VAL A 158
ILE A 161
MET A  43
None
1.42A 1opjA-3jtwA:
undetectable
1opjA-3jtwA:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vba ISOPROPYLMALATE/CITR
AMALATE ISOMERASE
SMALL SUBUNIT


(Methanocaldococcus
jannaschii)
PF00694
(Aconitase_C)
4 TYR A  94
VAL A   9
ILE A  81
MET A 148
None
1.17A 1opjA-3vbaA:
undetectable
1opjA-3vbaA:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aio LIMIT DEXTRINASE

(Hordeum vulgare)
PF02922
(CBM_48)
PF11852
(DUF3372)
4 TYR A 357
VAL A 450
ILE A 478
MET A 398
GOL  A1888 (-3.9A)
None
None
None
1.31A 1opjA-4aioA:
undetectable
1opjA-4aioA:
16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4avy PROBABLE SHORT-CHAIN
DEHYDROGENASE


(Pseudomonas
aeruginosa)
PF13561
(adh_short_C2)
4 TYR A 135
LYS A 150
VAL A  82
ILE A 153
None
1.37A 1opjA-4avyA:
undetectable
1opjA-4avyA:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c23 L-FUCULOSE KINASE
FUCK


(Streptococcus
pneumoniae)
PF00370
(FGGY_N)
PF02782
(FGGY_C)
4 TYR A  67
VAL A 211
ILE A  72
MET A  28
None
1.43A 1opjA-4c23A:
undetectable
1opjA-4c23A:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dqx PROBABLE
OXIDOREDUCTASE
PROTEIN


(Rhizobium etli)
PF13561
(adh_short_C2)
4 TYR A 161
LYS A 177
VAL A 106
ILE A 180
None
1.44A 1opjA-4dqxA:
0.5
1opjA-4dqxA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4v20 CELLOBIOHYDROLASE

(Aspergillus
fumigatus)
PF00840
(Glyco_hydro_7)
4 TYR A 109
VAL A 288
ILE A 428
MET A 367
None
1.29A 1opjA-4v20A:
undetectable
1opjA-4v20A:
19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xn3 TAIL SPIKE PROTEIN

(Salmonella
virus HK620)
no annotation 4 TYR A 356
VAL A 345
ILE A 310
MET A 359
None
1.40A 1opjA-4xn3A:
undetectable
1opjA-4xn3A:
18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z1a 2-DEHYDRO-3-DEOXYPHO
SPHOOCTONATE
ALDOLASE


(Helicobacter
pylori)
PF00793
(DAHP_synth_1)
4 TYR A 142
LYS A 146
ILE A 117
MET A 192
None
1.19A 1opjA-4z1aA:
undetectable
1opjA-4z1aA:
23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a5t EUKARYOTIC
TRANSLATION
INITIATION FACTOR 3
SUBUNIT A
EUKARYOTIC
TRANSLATION
INITIATION FACTOR 3
SUBUNIT M


(Oryctolagus
cuniculus)
PF01399
(PCI)
4 LYS M 331
VAL A 443
ILE M 325
MET M 277
None
1.15A 1opjA-5a5tM:
undetectable
1opjA-5a5tM:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d76 PUTATIVE PHAGE LYSIN

(Streptococcus
phage phi7917)
PF05257
(CHAP)
PF08460
(SH3_5)
4 TYR A 237
VAL A 214
ILE A 206
MET A  36
None
1.25A 1opjA-5d76A:
undetectable
1opjA-5d76A:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i6g ACETYL-COA
CARBOXYLASE-LIKE
PROTEIN,ACETYL-COA
CARBOXYLASE-LIKE
PROTEIN


(Chaetomium
thermophilum)
PF01039
(Carboxyl_trans)
PF08326
(ACC_central)
4 TYR A1547
VAL A1844
ILE A1614
MET A1609
None
1.40A 1opjA-5i6gA:
undetectable
1opjA-5i6gA:
14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jfc NADH-DEPENDENT
FERREDOXIN:NADP
OXIDOREDUCTASE
SUBUNIT ALPHA


(Pyrococcus
furiosus)
PF07992
(Pyr_redox_2)
PF14691
(Fer4_20)
4 TYR L 323
VAL L 260
ILE L 367
MET L 372
None
1.38A 1opjA-5jfcL:
undetectable
1opjA-5jfcL:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t53 N-ACETYLTRANSFERASE
ESCO1


(Homo sapiens)
PF13878
(zf-C2H2_3)
PF13880
(Acetyltransf_13)
4 TYR A 677
LYS A 681
VAL A 719
ILE A 685
None
0.89A 1opjA-5t53A:
undetectable
1opjA-5t53A:
19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tou PHYCOCYANIN BETA-1
SUBUNIT


(Pseudanabaena
sp. lw0831)
no annotation 4 TYR D 163
VAL D  52
ILE D 131
MET D 157
None
1.27A 1opjA-5touD:
undetectable
1opjA-5touD:
18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tru CYTOTOXIC
T-LYMPHOCYTE PROTEIN
4


(Homo sapiens)
PF07686
(V-set)
4 TYR c  25
VAL c  46
ILE c 108
MET c  99
None
1.44A 1opjA-5truc:
undetectable
1opjA-5truc:
17.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tul TETRACYCLINE
DESTRUCTASE TET(55)


(uncultured
bacterium)
PF01494
(FAD_binding_3)
4 TYR A  26
VAL A  33
ILE A 119
MET A  59
None
1.17A 1opjA-5tulA:
undetectable
1opjA-5tulA:
23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tvo S-ADENOSYLMETHIONINE
DECARBOXYLASE
PROENZYME


(Trypanosoma
brucei)
PF01536
(SAM_decarbox)
4 TYR B  81
VAL A 232
ILE A 237
MET A  91
None
1.40A 1opjA-5tvoB:
undetectable
1opjA-5tvoB:
11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yak -

(-)
no annotation 4 TYR A 184
VAL A 115
ILE A 190
MET A 261
None
1.32A 1opjA-5yakA:
1.0
1opjA-5yakA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ck9 35O22 SCFV LIGHT
CHAIN PORTION


(Homo sapiens)
no annotation 4 TYR E  68
LYS E  66
VAL E  97
ILE E  33
None
1.13A 1opjA-6ck9E:
undetectable
1opjA-6ck9E:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cn0 16S RRNA
(GUANINE(1405)-N(7))
-METHYLTRANSFERASE


(Proteus
mirabilis)
no annotation 4 LYS A 267
VAL A 258
ILE A 264
MET A 202
None
0.98A 1opjA-6cn0A:
1.0
1opjA-6cn0A:
14.95